Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...
Modality.AI and Target ALS are partnering on a clinical study of AI as a way to assess changes in speech and motor function ...
The new patent covers Neurosense's formulation of PrimeC, a fixed-dose combo of an approved antibiotic and anti-inflammatory.
ProJenX teamed with Unlearn to create digital twins of ALS patients as a placebo group in open-label extension of Phase 1 ...
The Mayo Clinic was awarded $12 million to support a study that will give ALS patients access to the investigational therapy ...
What is contentment, and is it even possible with the daily struggles of ALS? Columnist Kristin Neva offers her observations as a caregiver.
Living well with ALS means we must be mindful, writes columnist Dagmar Munn, who shares an anecdote about an unplanned long walk.
Bionews, Inc., the parent company of this site, has partnered with the following nonprofit advocacy organizations to help further the mission of ensuring that patients and caregivers are able to get ...
Enter Keyword. Search for Events by Keyword.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback